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Background: Somatic, but not cognitive–affective, symptoms of depression have
been associated with reduced heart rate variability (HRV), and with poor prognosis
in cardiovascular patients. However, factors concomitant with cardiovascular diseases
may confound the relationship between somatic symptoms of depression and reduced
HRV. Therefore, this study examined whether reduced HRV was differentially associated
with cognitive–affective and somatic symptoms of depression in medically healthy
individuals with and without dysphoria.
Methods: Self-reported cognitive–affective and somatic symptoms as measured with
the Beck Depression Inventory-II questionnaire and time and frequency domain
parameters of HRV were collected in 62 medically healthy individuals, of whom 25 with
and 37 without dysphoria.
Results: Somatic, but not cognitive–affective, symptoms of depression were inversely
associated with SD of NN intervals (β = −0.476, p < 0.05), number of interval
differences of successive NN intervals greater than 50 ms (NN50; β = −0.498, p <
0.03), and HRV total power (β = −0.494, p < 0.04) in the group with dysphoria,
after controlling for sex, anxiety, and lifestyle factors. Cognitive–affective and somatic
symptoms were not related to any of the HRV parameters in the group without dysphoria
(all ps > 0.24).
Conclusion: By showing that the relationship between somatic depressive symptoms
and reduced HRV extends to medically healthy individuals with dysphoria, the present
findings suggest that this association is independent of factors concomitant with
cardiovascular diseases. The present study also suggests that individuals with somatic
rather than cognitive–affective subsets of depressive symptoms may be at greater risk
for developing cardiovascular diseases.
Keywords: autonomic nervous system, cardiovascular risk, cognitive–affective symptoms, dysphoria, heart rate
variability, somatic symptoms
Introduction
Depression is an important and independent risk factor for the onset of coronary artery disease
(CAD) as well as for the adverse course and outcomes in patients with CAD (Wulsin and Singal,
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2003; Barth et al., 2004) or following myocardial infarction (MI;
Van Melle et al., 2004). Speciﬁcally, there is evidence that depres-
sion is associated with a 60% greater likelihood of having CAD
(Wulsin and Singal, 2003). Patients with depression are also more
likely to have a major cardiac event within a year of the diagnosis
of CAD (Carney et al., 1988), and/or to die in the years following
the diagnosis (Barefoot et al., 1996). Moreover, the presence of
depression in post-MI patients is associated with a 2- to 2.5-fold
increased risk of poor cardiovascular outcome (Van Melle et al.,
2004). It has been also reported that depression is a risk factor for
cardiac morbidity and/or mortality in patients who have under-
gone cardiac surgery (Lespérance et al., 2000; Blumenthal et al.,
2003).
The autonomic nervous system (ANS) has been identiﬁed
as a pivotal site of dysregulation, with reduced parasympathetic
and/or increased sympathetic activity leading to arrhythmias and
sudden cardiac death (Schwartz and Vanoli, 1981; Podrid et al.,
1990; Musselman et al., 1998). Given that depression itself is
associated with reduced parasympathetic and/or increased sym-
pathetic activity (Kemp et al., 2010), the presence of depression
is likely to potentiate the impaired parasympathetic control and
increased sympathetic activity observed in patients with CAD.
In turn, these depression-related ANS abnormalities may further
predispose depressed patients with CAD to ventricular tachy-
cardia, ventricular ﬁbrillation, myocardial ischemia, and sudden
cardiac death (Carney et al., 2002, 2005).
In line with these ﬁndings, reduced heart rate variability
(HRV), which reﬂects excessive sympathetic modulation and/or
inadequate cardiac vagal control, has been reported in psychi-
atric depressed individuals compared to healthy controls (Imaoka
et al., 1985; Dallack and Roose, 1990; Rechlin et al., 1994).
Importantly, there is even more evidence that depressed patients
with CAD or after MI have reduced HRV compared to non-
depressed individuals (Carney et al., 1995, 2001; for reviews, see
Carney et al., 2002, 2005; Shaﬀer et al., 2014). It has been recently
shown that an association between depression and reduced HRV
extends also to patients who underwent cardiac surgery (Patron
et al., 2012, 2014, 2015). Based on these ﬁndings, reduced HRV
has been suggested as one possible pathophysiological marker of
depression-related ANS dysregulation that has been implicated as
a risk factor for cardiac morbidity and/or mortality in CAD, post-
MI, or post-surgical patients (Carney et al., 2002, 2005; Patron
et al., 2012, 2014, 2015).
It should be noted, however, that some studies failed to repli-
cate the association between depression and reduced HRV in
patients with CAD (Gehi et al., 2005) or post-MI (Martens
et al., 2008). One possible explanation for these inconsistent
ﬁndings may lie in the heterogeneity of depressive symptoms
(Kemp et al., 2014), including cognitive–aﬀective (e.g., nega-
tive self-image, guilt) and somatic (e.g., sleep problems, poor
appetite, fatigue) symptoms. Indeed, a reanalysis of data from
Gehi et al. (2005) showed that somatic, but not cognitive–
aﬀective, symptoms of depression were associated with reduced
HRV in patients with stable CAD (de Jonge et al., 2007).
Consistent with this ﬁnding, several lines of evidence have
shown that cardiovascular prognosis is associated with somatic,
but not cognitive–aﬀective, depressive symptoms (e.g., Watkins
et al., 2003; de Jonge et al., 2006; Linke et al., 2009; Roest
et al., 2011). Speciﬁcally, Watkins et al. (2003) showed that
medical comorbidity in patients with acute MI were more
strongly associated with somatic than cognitive–aﬀective depres-
sive symptoms. Likewise, de Jonge et al. (2006) reported
that somatic, but not cognitive–aﬀective, symptoms of depres-
sion were related to poor cardiovascular prognosis in patients
2.5 years after MI, a ﬁnding that has been replicated by oth-
ers (Smolderen et al., 2009; Martens et al., 2010; Roest et al.,
2011). Notably, Linke et al. (2009) and Schiﬀer et al. (2009)
have recently extended these ﬁndings to women with suspected
myocardial ischemia and patients with chronic heart failure,
respectively.
Despite the intriguing evidence suggesting that somatic, but
not cognitive–aﬀective, symptoms of depression may diﬀeren-
tially impact cardiovascular risk by reducing HRV (de Jonge
et al., 2007), research on depression and HRV has been typi-
cally conducted in cardiovascular patients (Kemp et al., 2010).
Therefore, many factors concomitant with cardiovascular dis-
eases (e.g., disease severity, the presence of comorbid medical
conditions) may confound the observed association between
somatic symptoms of depression and reduced HRV (Carney
and Freedland, 2012). Another important condition that may
impact the relationship between somatic symptoms and HRV
in cardiovascular patients with depression is the presence of
anxiety symptoms. Some studies have suggested that anxiety –
a comorbid condition reported in more than 60% of patients
with major depression disorder (MDD; Kessler et al., 2005) –
rather than depression is associated with reduced HRV (Thayer
and Lane, 2000; Cohen and Benjamin, 2006; Friedman, 2007;
Rottenberg, 2007; Miu et al., 2009), and with the risk of car-
diovascular diseases (Cohen and Benjamin, 2006; Vogelzangs
et al., 2010). Consistent with these ﬁndings, Martens et al.
(2008) have shown that anxiety, but not depression, was asso-
ciated with reduced HRV. Surprisingly, despite this converg-
ing evidence, the majority of studies examining the relation-
ship between depression and reduced HRV in cardiovascu-
lar patients did not control for the eﬀects of anxiety (e.g.,
Carney et al., 1995, 2001; Stein et al., 2000; de Jonge et al.,
2007).
In light of these considerations, it is crucial to examine
whether HRV is diﬀerentially associated with subsets of depres-
sive symptoms in medically healthy individuals, while con-
trolling for anxiety symptoms. At present, only one study to
our knowledge has examined whether symptom dimensions
of depression were diﬀerentially related to HRV in medically
healthy preadolescents (Bosch et al., 2009). Speciﬁcally, con-
sistent with ﬁndings observed in patients with cardiovascu-
lar disease, Bosch et al. (2009) reported that somatic, but not
cognitive–aﬀective, depressive symptoms were inversely associ-
ated with HRV and baroreﬂex sensitivity. However, the results
by Bosch et al. (2009) were limited to the preadolescent popula-
tion, aged between 10 and 12 years. This limitation is even more
important when one considers that HRV parameters reach their
maximum at about 20 and 30 years of age (Korkushko et al.,
1991), and diﬀer between healthy individuals aged 10 years and
those aged >16 years (Silvetti et al., 2001). In addition, Bosch
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et al. (2009) did not control for the potential eﬀect of anxiety
on the relationship between somatic depressive symptoms and
reduced HRV.
Therefore, the aim of the present study was to examine
whether somatic and cognitive–aﬀective symptoms of depres-
sion would be diﬀerentially associated with time and fre-
quency domain parameters of HRV in medically healthy indi-
viduals aged 18–30 years, while controlling for sex, anx-
iety, and lifestyle factors. Based on previous ﬁndings (de
Jonge et al., 2007; Bosch et al., 2009), it was hypothe-
sized that HRV parameters would be inversely related to
somatic, but not cognitive–aﬀective, symptoms of depres-
sion. Given that somatic, but not cognitive–aﬀective, subsets
of depressive symptoms are distributed taxonomically (Beach
and Amir, 2003), it is possible that depression may inﬂu-
ence HRV parameters only when somatic depressive symp-
toms exceed a certain threshold of severity. Therefore, it was
also examined whether somatic or cognitive–aﬀective symp-
toms of depression would be diﬀerentially correlated with
HRV parameters in individuals with or without dysphoria.
To this end, we divided the whole sample into two sub-
groups depending on the presence/absence of dysphoria. It
was expected that somatic depressive symptoms would be
inversely related to HRV parameters in individuals with,
but not without, dysphoria.
Materials and Methods
Participants
After local Ethics Committee approval, 62 undergraduate stu-
dents from the University of Padova were enrolled in the present
study. Participants were mostly females (n = 54; 87%), with a
mean (SD) age of 21.9 (2.0). None of the participants were taking
antidepressants or medications known to aﬀect ANS functioning
or had a history of neurological or cardiovascular disease. The
descriptive statistics are reported in Table 1.
Assessment of Depressive and Anxiety
Symptoms
Depressive symptoms were assessed using the Beck Depression
Inventory-II (BDI-II; Beck et al., 1996; Ghisi et al., 2006). The
BDI-II is a reliable and valid self-report questionnaire that
evaluates the severity of symptoms of depression in the past
2 weeks. Answers are given on a four-point (0–3) Likert scale
and scores range from 0 to 63, with higher scores indicating
more severe depressive symptoms. Of note, there is large evi-
dence that the BDI-II is a reliable and valid measure of the
severity of depressive symptoms in community samples (Lasa
et al., 2000) and college populations (Sprinkle et al., 2002). In
the Italian version, a score of 12 has been identiﬁed as an
optimal cut-oﬀ to discriminate individuals with and without
problems of depression in the Italian population (Ghisi et al.,
2006).
The structure of the BDI-II has been examined in several
studies using factor analysis (Ward, 2006). A two-factor solu-
tion has been frequently reported in non-clinical (Whisman et al.,
2000; Storch et al., 2004) and clinical samples (Beck et al., 1996;
Steer et al., 1998, 1999). Speciﬁcally, the two-factor solution usu-
ally comprises a cognitive–aﬀective factor and a somatic factor
in non-clinical individuals (mostly students; Beck et al., 1996;
Whisman et al., 2000; Storch et al., 2004; Ward, 2006) as well
as in psychiatric patients (Beck et al., 1996; Steer et al., 1998,
1999). Separate scores for each factor were calculated for each
participant.
The module A of the Structured Clinical Interview (SCID-I)
for the DSM-IV Axis I (First et al., 1997; Italian version by Mazzi
et al., 2000) was administered in order to conﬁrm the presence
of dysphoria (i.e., at least two current symptoms of depression;
Judd et al., 1994; Maier et al., 1997) and to exclude individuals
with major depression, dysthymia, or bipolar disorder.
Self-reported trait anxiety symptoms were assessed using the
State–Trait Anxiety Inventory, form Y2 (STAI-Y2; Spielberger
et al., 1996). The STAI form Y1 and Y2 is composed by two 20-
item four-point Likert scales that measure state and trait anxiety,
respectively. State anxiety represents the individual’s ﬂuctuant
and transitory anxiety, whereas trait anxiety indicates long-
lasting and persistent anxiety. Accordingly, test-retest reliability
within a 1-month interval is very high for STAI-Y2 (r = 0.82),
which evaluates the stable trait of anxiety, whereas it is moder-
ate for STAI Y1 (r = 0.49), which, in turn, evaluates current and
time-dependent anxiety. Raw scores range between 20 and 80 for
both scales, with higher scores reﬂecting higher levels of trait or
state anxiety. Given that reduced HRV is more likely to be asso-
ciated with trait rather than state anxiety, we included only trait
anxiety in the statistical analyses.
HRV Recordings
The electrocardiogram (ECG) was recorded using Ag/AgCl sur-
face electrodes positioned on the participant’s chest in a modiﬁed
lead II conﬁguration. The ECG signal was ampliﬁed with a gain
TABLE 1 | Characteristics of the participants enrolled in the study.
Variables Participants (n = 62)
Female sex 54 (87)
Age (years) 21.9 (2.0)
Education (years) 15.8 (1.3)
Current smoker 24 (39)
Regular alcohol use 6 (10)
STAI-Y2 42.2 (12.5)
BDI-II 8.4 (7.1)
Cognitive–affective symptoms 4.4 (4.7)
Somatic symptoms 4.0 (3.1)
HR (bpm) 77.1 (11.8)
SDNN (ms) 54.2 (19.9)
rMSSD (ms) 42.5 (24.2)
NN50 count 74.7 (57.0)
Data are M (SD) of continuous and N (%) of categorical variables. BDI-II, Beck
Depression Inventory-II; HR, heart rate; bpm, beats per minute; SDNN, standard
deviation of NN intervals; rMSSD, the square root of the mean of the sum of the
squares of differences between adjacent NN intervals in ms; NN50, number of
interval differences of successive NN intervals greater than 50 ms.
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of 150, bandpass ﬁltered (0.3–100 Hz, to avoid distortions of the
T-wave signal), digitized at 500 Hz (16 bit A/D converter; resolu-
tion 0.559 μV/LSB), and stored on to a Pentium IV computer.
Impedance was kept below 5 k. The ECG signal was ampli-
ﬁed and ﬁltered by a SynAmps unit ampliﬁer (Neuroscan, Inc.,
Compumedics, Ltd, El Paso, TX, USA). A digital trigger detect-
ing R-waves was applied to the ECG signal to obtain RR intervals,
corresponding to the inverse of heart rate (HR). All ECG data
were visually inspected and artifacts were corrected with a piece-
wise cubic spline interpolation method that generates missing or
corrupted values into RR intervals. Then, time domain parame-
ters of HRVwere calculated by Kubios HRVAnalysis Software 2.0
(The Biomedical Signal Analysis Group, Department of Applied
Physics, University of Kuopio, Finland). Time domain param-
eters, which are measures of the total variation of HR, were
calculated as follows:
(1) Standard deviation of NN intervals (SDNN) expressed in
ms, which reﬂects the cyclic components responsible for the
variability of HR (Task Force of the European Society of
Cardiology, and the North American Society for pacing, and
electrophysiology, 1996);
(2) Root mean square of successive diﬀerence of NN inter-
vals (rMSSD) expressed in ms, which reﬂects estimates of
short−term variability of HR. rMSSD is highly sensitive to
the ﬂuctuation of high frequency (HF) of HRV and is an
index of cardiac vagal control (Task Force of the European
Society of Cardiology, and the North American Society for
pacing, and electrophysiology, 1996);
(3) Number of interval diﬀerences of successive NN intervals
greater than 50 ms in the entire recording (NN50), which
reﬂects estimates of short−term variability of HR and is an
index of cardiac vagal control (Task Force of the European
Society of Cardiology, and the North American Society for
pacing, and electrophysiology, 1996).
Fast Fourier spectral analysis was then applied on the NN
series to compute frequency domain indexes, which, in turn, were
calculated as follows:
(1) HRV total power in ms2, which reﬂects the variance of
all NN intervals (Task Force of the European Society of
Cardiology, and the North American Society for pacing, and
electrophysiology, 1996);
(2) HF power (0.15–0.40 Hz) in ms2, which primarily reﬂects
cardiac parasympathetic tone (Task Force of the European
Society of Cardiology, and the North American Society for
pacing, and electrophysiology, 1996).
All frequency domain indexes were logarithmically trans-
formed to normalize their distribution.
Procedure
Upon arrival at the laboratory, the participants read and signed
an informed consent form and completed the BDI-II and STAI-
Y2 questionnaires. In order to conﬁrm the presence of dysphoria
and to exclude the presence of major depression, dysthymia,
or bipolar disorder, all the participants were administered the
SCID-I for the DSM-IV by a trained psychologist. The partici-
pants completed an ad hoc interview that provided information
on their age, health status, smoking habits, and regular alcohol
use. Then, each participant was seated in a comfortable arm-
chair in a sound-attenuated, dimly-lit room. After the electrodes
were attached, the ECG was continuously recorded at rest over
a 5-min period. In order to avoid movement artifacts, partici-
pants were instructed to stay still and not to talk during the ECG
recordings.
Statistical Analysis
According to the two-factor structure by Carvalho Bos et al.
(2009), cognitive–aﬀective symptoms were calculated by sum-
ming the scores of 12 BDI-II items for each individual: inde-
cisiveness, worthlessness, loss of pleasure, punishment feelings,
past failure, pessimism, self-criticalness, sadness, loss of interest,
self-dislike, guilty feelings, and suicidal thoughts. Somatic symp-
toms were calculated by summing the scores of the remaining
nine BDI-II items: agitation, changes in appetite, crying, tiredness
or fatigue, loss of energy, irritability, changes in sleeping pat-
tern, concentration diﬃculty, and loss of interest in sex. Internal
consistency measured by Cronbach’s alpha was high for both
the cognitive–aﬀective factor (Cronbach’s alpha = 0.88) and the
somatic factor (Cronbach’s alpha = 0.78).
As our ﬁrst step, a linear regression model was used to predict
HR, SDNN, rMSSD,NN50, HRV total power, andHF power from
the overall depressive symptoms (i.e., the total BDI-II score) with
the group as a whole. Then, linear regression models were used
to examine whether cognitive–aﬀective and/or somatic symp-
toms were associated with HR, SDNN, rMSSD, NN50, HRV total
power, and HF power.
As our second step, the whole sample was divided in two
subgroups depending on the presence of dysphoria. In line with
recommendations for the use of the BDI-II in non-clinical sam-
ples, and for categorization of research participants (see Kendall
et al., 1987; Haaga and Solomon, 1993; Tennen et al., 1995;
Frewen and Dozois, 2005), individuals who scored equal to or
greater than 12 on the BDI-II, had at least two current depres-
sive symptoms, at least 2 weeks in duration, and did not meet
the diagnostic criteria for major depression, dysthymia, or bipolar
disorder were assigned to the group with dysphoria (n = 25). The
participants who scored lower than 12 on the BDI-II and had no
current symptoms of depression or previous diagnosis of major
depression, dysthymia, or bipolar depression were assigned to the
group without dysphoria (n = 37). Chi-square or Fisher’s exact
test or analyses of variance (ANOVAs) were used to compare the
groups in terms of sex, age, smoking habits, regular alcohol use,
cognitive–aﬀective, and somatic symptoms, and anxiety symp-
toms. Linear regression models were used to examine whether
overall depressive symptoms were associated with HR, SDNN,
rMSSD, NN50, HRV total power, and HF power separately in
the group with vs. without dysphoria. Then, linear regression
models were used to predict HR, SDNN, rMSSD, NN50, HRV
total power, and HF power from cognitive-aﬀective, and somatic
symptoms in both groups separately. Sex, anxiety symptoms,
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smoking habits, and regular alcohol use were included as covari-
ates in each regression model. Age was not included as a covariate
in the regression models due to the small age range of partici-
pants (SDs ≤ 2.0). In addition, all the participants were between
19 and 27 years of age, when HRV parameters reach their max-
imum and become stable (Korkushko et al., 1991; Silvetti et al.,
2001). A p-value of <0.05 was considered statistically signiﬁcant.
Results
Somatic vs. Cognitive–Affective Symptoms
and HRV
When considering the group as a whole, overall depressive symp-
toms were not associated with any of the autonomic measures (all
ps > 0.31). In addition, HR, SDNN, rMSSD, NN50, HRV total
power, and HF power were not predicted by cognitive–aﬀective
symptoms of depression (all ps > 0.67). Similarly, somatic symp-
toms of depression were unrelated to HR, SDNN, rMSSD, NN50,
HRV total power, and HF power (all ps > 0.33).
Somatic vs. Cognitive–Affective Symptoms
and HRV in Individuals with vs. without
Dysphoria
The groups did not diﬀer in terms of sex (p = 0.46), with a
predominance of female students both in the group with dys-
phoria (n = 23, 92%) and in the group without dysphoria
(n = 31, 84%). The groups did not diﬀer in terms of smok-
ing habits: the current smokers were 6 (24%) and 18 (49%) in
the group with and without dysphoria (p = 0.05), respectively.
Similarly, the groups did not diﬀer in terms of regular alcohol
use (p = 0.39), with one (4%) and ﬁve (14%) regular alcohol
drinkers in the group with and without dysphoria, respectively.
The mean age was slightly higher in the group without dyspho-
ria (M = 22.4, SD = 2.0) compared to the group with dysphoria
(M = 21.2, SD = 1.8; p < 0.03). Overall depressive symptoms
as well as cognitive–aﬀective and somatic symptoms were signif-
icantly higher in the group with dysphoria (total BDI-II score,
M = 15.8, SD = 4.0; cognitive–aﬀective symptoms, M = 9.0,
SD = 3.9; somatic symptoms, M = 6.8, SD = 1.8) than without
dysphoria (total BDI-II score, M = 3.3, SD = 3.0; cognitive–
aﬀective symptoms, M = 1.2, SD = 1.4; somatic symptoms,
M = 2.1, SD = 2.3; all ps < 0.001). Likewise, anxiety symptoms,
as assessed with the STAI-Y2, were higher in the group with dys-
phoria (M = 53.6, SD = 9.4) than without dysphoria (M = 34.6,
SD = 7.5, p < 0.001).
With respect to the group with dysphoria, the total BDI-II
scores were not associated with any of the autonomic measures
(all ps> 0.07). Linear regressions showed that somatic symptoms
were signiﬁcantly associated with SDNN, NN50, and HRV total
power. Speciﬁcally, higher somatic symptoms were associated
with lower SDNN, NN50, and HRV total power in the group with
dysphoria. It is worth noting that these signiﬁcant associations
were independent of sex, anxiety symptoms, smoking habits,
and regular alcohol use. By contrast, cognitive–aﬀective symp-
toms were unrelated to SDNN, NN50, and HRV total power in
the group with dysphoria. Both cognitive–aﬀective and somatic
symptoms were not associated with HR, rMSSD, and HF power.
All the statistical details of the regression analysis in the group
with dysphoria are reported in Table 2.
With respect to the group without dysphoria, the total BDI-II
scores were not associated with any of the autonomic measures
TABLE 2 | Results of linear regression analysis with cognitive–affective or somatic symptoms predicting HRV parameters in the group with dysphoria.
HRV parameters B 95% CI of B SE B β p R2
HR∗ 0.209
Cognitive–affective symptoms 0.986 −1.398 to 3.369 1.134 0.276 0.396
Somatic symptoms 2.487 −1.531 to 6.505 1.913 0.327 0.210
SDNN∗ 0.382
Cognitive–affective symptoms −1.831 −5.509 to 1.847 1.751 −0.294 0.309
Somatic symptoms −6.321 −12.522 to −0.120 2.952 −0.476 0.046
rMSSD∗ 0.203
Cognitive–affective symptoms −1.896 −7.414 to 3.622 2.626 −0.230 0.480
Somatic symptoms −5.752 −15.055 to 3.552 4.428 −0.328 0.210
NN50∗ 0.460
Cognitive–affective symptoms −0.665 −9.191 to 7.861 4.058 −0.043 0.872
Somatic symptoms −16.398 −30.774 to −2.022 6.843 −0.498 0.028
lnHRV total power∗ 0.417
Cognitive–affective symptoms −0.088 −0.203 to 0.026 0.054 −0.442 0.123
Somatic symptoms −0.210 −0.403 to −0.017 0.092 −0.494 0.034
lnHF∗ 0.318
Cognitive–affective symptoms −0.020 −0.185 to 0.146 0.079 −0.074 0.805
Somatic symptoms −0.201 −0.480 to 0.078 0.133 −0.353 0.147
∗Model controlling for sex, anxiety symptoms, current smoking, and regular alcohol use. HRV, heart rate variability; HR, heart rate; SDNN, standard deviation of NN
intervals; rMSSD, the square root of the mean of the sum of the squares of differences between adjacent NN intervals in ms; NN50, number of interval differences of
successive NN intervals greater than 50 ms; lnHRV total power, log of heart rate variability total power in ms2; lnHF, log of high frequency power in ms2; B, non-standardized
regression coefficient; SE B, standard error; β, standardized regression coefficient; 95% CI, 95% confidence interval.
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TABLE 3 | Results of linear regression analysis with cognitive–affective or somatic symptoms predicting HRV parameters in the group without dysphoria.
HRV parameters B 95% CI of B SE B β p R2
HR∗ 0.293
Cognitive–affective symptoms 0.925 −1.646 to 3.496 1.259 0.128 0.468
Somatic symptoms 0.873 −0.644 to 2.390 0.743 0.199 0.249
SDNN∗ 0.082
Cognitive−affective symptoms 0.900 −3.841 to 5.640 2.321 0.077 0.701
Somatic symptoms −0.351 −3.148 to 2.446 1.370 −0.049 0.799
rMSSD∗ 0.050
Cognitive−affective symptoms 0.274 −4.704 to 5.253 2.438 0.023 0.911
Somatic symptoms 0.330 −2.608 to 3.268 1.438 0.045 0.820
NN50∗ 0.022
Cognitive−affective symptoms 1.601 −15.083 to 18.284 8.169 0.040 0.846
Somatic symptoms 1.324 −8.521 to 11.168 4.820 0.055 0.785
lnHRV total power∗ 0.111
Cognitive−affective symptoms 0.059 −0.149 to 0.267 0.102 0.113 0.567
Somatic symptoms −0.037 −0.159 to 0.086 0.060 −0.116 0.546
lnHF∗ 0.084
Cognitive−affective symptoms 0.061 −0.226 to 0.349 0.141 0.087 0.666
Somatic symptoms 0.032 −0.138 to 0.202 0.083 0.074 0.702
∗Model controlling for sex, anxiety symptoms, current smoking, and regular alcohol use. HRV, heart rate variability; HR, heart rate; SDNN, standard deviation of NN
intervals; rMSSD, the square root of the mean of the sum of the squares of differences between adjacent NN intervals in ms; NN50, number of interval differences of
successive NN intervals greater than 50 ms; lnHRV total power, log of HR variability total power in ms2; lnHF, log of high frequency power in ms2; B, non-standardized
regression coefficient; SE B, standard error; β, standardized regression coefficient; 95% CI, 95% confidence interval.
(all ps > 0.12). Similarly, the cognitive–aﬀective and somatic
symptoms did not predict any of the HRV parameters. All the
statistical details of the regression analysis in the group without
dysphoria are reported in Table 3.
Discussion
The present study examined whether cognitive–aﬀective and
somatic symptoms of depression were diﬀerentially associated
with time domain parameters of HRV in healthy individuals.
Overall, self-reported depressive symptoms (i.e., the total BDI-
II score) were not associated with any of the HRV parameters
either when the group was considered as a whole or when par-
ticipants were divided into a group with and a group without
dysphoria. Similarly, no signiﬁcant eﬀects of cognitive–aﬀective
or somatic symptoms on any of the HRV parameters in the group
as a whole or in individuals without dysphoria were noted. By
contrast, SDNN, NN50, and HRV total power were signiﬁcantly
predicted by somatic, but not cognitive–aﬀective, symptoms of
depression in the group with dysphoria, while controlling for
sex, anxiety symptoms, smoking habits, and regular alcohol use.
Speciﬁcally, the somatic symptoms were inversely associated
with SDNN, NN50, and HRV total power. Both somatic and
cognitive–aﬀective symptoms were unrelated to HR, rMSSD, and
HF power in the group with dysphoria.
Our results are in line with previous ﬁndings showing an
inverse association between somatic, but not cognitive–aﬀective,
symptoms of depression and HRV in patients with stable CAD
(de Jonge et al., 2007). These novel ﬁndings add to the litera-
ture on the physiological mechanisms underlying the association
between depression and cardiovascular diseases by showing that
an inverse relationship between somatic depressive symptoms
and HRV is present even in healthy individuals. Accordingly,
the present data provide preliminary evidence that the relation-
ship between somatic symptoms of depression and reduced HRV
is independent of factors concomitant with cardiovascular dis-
eases such as disease severity or the presence of comorbid medical
conditions. Of note, the present study also showed that the
relationship between somatic depressive symptoms and reduced
HRV was independent of anxiety symptoms. The latter result
is consistent with previous studies showing that depression, but
not anxiety, is associated with reduced HRV (e.g., Pitzalis et al.,
2001) and cardiovascular risk (e.g., Jiang et al., 2004). However, it
should be noted that anxiety is comorbid with depression inmore
than 60% of cases (Kessler et al., 2005), and that anxiety rather
than depression has been associated with reduced HRV in psy-
chiatric or cardiovascular patients (e.g., Friedman, 2007; Martens
et al., 2008). Clearly, future studies are warranted to examine the
relative contribution of depression and anxiety to reduced HRV
and cardiovascular risk in both clinical and non-clinical samples
(Carney et al., 2000).
Our results are likely to explain why some studies did not
ﬁnd any association between overall depressive symptoms and
reduced HRV in patients with CAD (Gehi et al., 2005) or post-MI
(Martens et al., 2008). Likewise, the present results also provide an
explanation for the inconsistent ﬁndings concerning the associa-
tion between depressive symptoms and reduced HRV in psychi-
atric patients (e.g., Dallack and Roose, 1990; Yeragani et al., 1991;
Rechlin et al., 1994; Moser et al., 1998). More speciﬁcally, the
present ﬁndings are consistent with previous studies suggesting
that depression is a heterogeneous disorder and that only speciﬁc
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subsets of symptomsmay be related to poor cardiovascular health
in individuals with dysphoria. Importantly, the ﬁnding that low
HRV is associated with somatic symptoms of depression sug-
gests that somatic rather than cognitive–aﬀective symptoms are
more likely to be implicated in the development of cardiovascu-
lar disease in medically healthy individuals with dysphoria. It is
well-established, indeed, that reducedHRV reﬂects ANS dysfunc-
tions, which, in turn, may predispose individuals with depression
to ventricular tachycardia, ventricular ﬁbrillation, myocardial
ischemia, and sudden cardiac death (Carney et al., 2002, 2005).
In line with this suggestion, somatic, but not cognitive–aﬀective,
symptoms of depression have been associated with low HRV (de
Jonge et al., 2007), and with poor prognosis in cardiovascular
patients (e.g., Watkins et al., 2003; de Jonge et al., 2006; Linke
et al., 2009; Roest et al., 2011).
Along the same line of reasoning, it is important to note that
somatic symptoms of depression were inversely related to SDNN
of HRV. Among time domain parameters of HRV, the SDNN has
been considered as one of the most accurate predictors of mor-
tality in post-MI patients (Kleiger et al., 1987; Stein et al., 2000).
Speciﬁcally, Kleiger et al. (1987) have reported that the risk of
mortality is 5.3 higher in post-MI patients with SDNN < 50 ms
compared to patients with SDNN > 100 ms. Clearly, longitu-
dinal studies are warranted to examine whether SDNN may be
a marker of the risk of cardiovascular diseases associated with
somatic symptoms of depression.
Our results are also in line with previous ﬁndings by Bosch
et al. (2009) showing that somatic symptoms of depression were
related with low HRV in healthy preadolescents. However, some
diﬀerences also exist between ﬁndings by Bosch et al. (2009)
and those reported in the present study. First, while Bosch et al.
(2009) found an inverse association between somatic symptoms
of depression and HRV in the whole sample, we observed this
relationship only in individuals with dysphoria (i.e., with a BDI-
II score equal to or greater than 12 and at least two current
depressive symptoms, at least 2 weeks in duration). An explana-
tion that reconciles our ﬁndings with those by Bosch et al. (2009)
is that the inverse relationship between somatic symptoms and
HRV becomes much stronger when somatic symptoms exceed a
threshold of severity. Second, in line with de Jonge et al.’s (2007),
we observed that cognitive–aﬀective symptoms were unrelated
to HRV parameters, whereas Bosch et al. (2009) found an unex-
pected positive association between cognitive–aﬀective symp-
toms andHRV parameters. This discrepant ﬁnding may be due to
the diﬀerent measurement instruments used. Speciﬁcally, while
the BDI-II questionnaire reﬂects the criteria of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV;
American Psychiatric Association, 1994), and accurately delin-
eates cognitive and somatic depressive symptoms (Dozois et al.,
1998), the Youth Self-Report (YSR; Achenbach and Rescorla,
2001) used by Bosch et al. (2009) was not developed to evalu-
ate depressive symptoms according to the DSM-IV criteria. In
addition, given that low internal consistency for both subscales
of the YSR has been reported by Bosch et al. (2009), it is possible
that the cognitive–aﬀective scale of the YSR was heterogeneous,
potentially biasing the relationship between cognitive–aﬀective
symptoms and HRV.
Although there is consistent evidence that increased sympa-
thetic and/or parasympathetic cardiac control may represent one
of the pathophysiological mechanisms linking depression to car-
diovascular diseases, the relative contribution of the sympathetic
and parasympathetic ANS to depression as a risk factor for car-
diovascular diseases is still debated (Carney et al., 2001, 2005).
Given that parasympathetic control exceeds sympathetic inﬂu-
ence on the variability of resting HR time series (i.e., the HRV),
the SDNN, as an estimate the overall HRV, is more likely to reﬂect
cardiac vagal rather than sympathetic control (Task Force of the
European Society of Cardiology, and the North American Society
for pacing, and electrophysiology, 1996). In line with the de Jonge
et al.’s ﬁndings (2007), our data suggest that somatic symptoms
of depression may be associated with poor cardiac vagal con-
trol in medically healthy individuals with depressive symptoms.
Consistent with our hypothesis, the NN50 count, which esti-
mates HF variation in HR (Task Force of the European Society of
Cardiology, and the North American Society for pacing, and elec-
trophysiology, 1996), was also inversely associated with somatic
symptoms of depression. However, given that rMSSD and HF
power were unrelated to somatic symptoms in individuals with
dysphoria, it remains unclear whether the inverse relationship
between somatic symptoms and HRV is actually mediated by
reduced cardiac vagal control (Bosch et al., 2009).
The present study has strengths and limitations. Individuals
with cardiovascular illness were excluded from the present study,
thus avoiding the potential confounding eﬀects of cardiovascu-
lar disease on the association between somatic symptoms and
reduced HRV. Also, this is the ﬁrst study to our knowledge that
examined the diﬀerential association between subsets of depres-
sive symptoms and HRVwhile controlling for anxiety symptoms.
Some limitations to be noted include the relatively small
sample size and, therefore, the fact that we did not conduct a
factor analysis on our factor structure. However, the two-factor
solution (cognitive–aﬀective vs. somatic symptoms of depres-
sion) has been widely used in non-clinical (e.g., Whisman et al.,
2000; Storch et al., 2004; Bosch et al., 2009) and clinical sam-
ples (e.g., Beck et al., 1996; Steer et al., 1998, 1999; de Jonge
et al., 2007). Speciﬁcally, the two-factor solution in non-clinical
samples (mostly students) usually consists of a ﬁrst, cognitive–
aﬀective factor (Factor 1), and of a second, somatic factor (Factor
2; Beck et al., 1996; Whisman et al., 2000; Storch et al., 2004).
In psychiatric patients, the somatic–aﬀective factor is usually the
ﬁrst factor obtained and the cognitive factor is the second fac-
tor identiﬁed (Beck et al., 1996; Steer et al., 1998, 1999). Given
that our study was focused on undergraduates with and without
dysphoria, we adopted the two-factor solution with a cognitive–
aﬀective factor and a somatic factor (Carvalho Bos et al., 2009). In
addition, in order to balance the number of items included in the
two factors, we assigned each item either to cognitive–aﬀective
or somatic dimensions according to the two-factor structure
obtained by Carvalho Bos et al. (2009). The high internal consis-
tency of the cognitive–aﬀective and somatic dimensions conﬁrms
the adequacy of the two-factor structure used in the present study.
Second, most somatic symptoms of depression (e.g., fatigue,
change in appetite, sleep problems) overlap with characteristics
of vital exhaustion, a condition known to be associated with the
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risk for future coronary diseases (Appels et al., 1987). In addi-
tion, fatigue, which can be considered as one of the key symptoms
of both depression and vital exhaustion or as a symptom by
itself (Kop, 2012), has been consistently reported as a risk fac-
tor for cardiac diseases (e.g., McSweeney et al., 2003). Therefore,
the association between somatic symptoms of depression and
cardiac risk, as reﬂected by reduced HRV, may be confounded
by vital exhaustion and/or fatigue. However, it should be noted
that somatic depressive symptoms have been shown to predict
mortality in patients with heart failure even after controlling for
exertion fatigue (Smith et al., 2012). Targeted treatment stud-
ies and experimental designs are needed to examine the rela-
tive contribution of somatic depressive symptoms, vital exhaus-
tion and fatigue to cardiac risk, as indicated by reduced HRV.
Third, although we controlled for the eﬀect of smoking sta-
tus and alcohol use, other unhealthy life-style factors, such as
poor dietary intake or physical inactivity, may confound the
relationship between somatic depressive symptoms and reduced
HRV (Kop, 2012). Future research should examine whether
the association between somatic symptoms of depression and
reduced HRV is independent of poor dietary intake and physi-
cal inactivity, which have been previously associated with reduced
HRV (Puig et al., 1993; Mozaﬀarian et al., 2008). Finally, given
that this study used cross-sectional data, causality could not be
inferred. However, the present study aimed at examining whether
time domain HRV parameters were diﬀerentially associated with
somatic rather than cognitive–aﬀective symptoms of depression,
but we do not claim that reduced HRV is either the cause or
the result of cognitive–aﬀective and/or somatic depressive symp-
toms. Clearly, further research should speciﬁcally address this
issue.
Based on the present ﬁndings, future studies aimed at
examining the relationship between depression and reduced
HRV in cardiovascular patients should take into account the
diﬀerential impact of cognitive–aﬀective and somatic symp-
toms on ANS functioning. From a clinical point of view,
the present study suggests that somatic rather than cognitive–
aﬀective symptoms of depression are more likely to be impli-
cated in the depression-related risk of developing cardio-
vascular diseases in medically healthy individuals with dys-
phoria. The longitudinal evaluation of subsets of depressive
symptoms, HRV parameters, and cardiovascular health is cru-
cial to determine whether a reduced SDNN associated with
somatic symptoms may predict the onset of cardiovascu-
lar disease in medically healthy individuals with depressed
mood.
References
Achenbach, T. M., and Rescorla, L. A. (2001). Manual for ASEBA School-Age
Forms and Proﬁles. Burlington, VT: University of Vermont, Research Center
for Children, Youth, and Families.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of
Mental Disorders, 4th Edn. Washington, DC: American Psychiatric Association.
Appels, A., Hoppener, P., and Mulder, P. (1987). A questionnaire to assess pre-
monitory symptoms of myocardial infarction. Int. J. Cardiol. 17, 15–24. doi:
10.1016/0167-5273(87)90029-5
Barefoot, J. C., Helms, M. J., Mark, D. B., Blumenthal, J. A., Caliﬀ, R. M., Haney,
T. L., et al. (1996). Depression and long-term mortality risk in patients with
coronary artery disease. Am. J. Cardiol. 78, 613–617. doi: 10.1016/S0002-
9149(96)00380-3
Barth, J., Schumacher, M., and Herrmann-Lingen, C. (2004). Depression as
a risk factor for mortality in patients with coronary heart disease: a
meta-analysis. Psychosom. Med. 66, 802–813. doi: 10.1097/01.psy.0000146332.
53619.b2
Beach, S. R., and Amir, N. (2003). Is depression taxonic, dimensional, or both?
J. Abnorm. Psychol. 112, 228–236. doi: 10.1037/0021-843X.112.2.228
Beck, A. T., Steer, R. A., and Brown, G. K. (1996). Beck Depression Inventory, 2nd
Edn Manual. San Antonio, TX: The Psychological Corporation Harcourt Brace
& Company.
Blumenthal, J. A., Lett, H. S., Babyak, M. A., White, W., Smith, P. K., Mark,
D. B., et al. (2003). Depression as a risk factor for mortality after coro-
nary artery bypass surgery. Lancet 362, 604–609. doi: 10.1016/S0140-6736(03)
14190-6
Bosch, N. M., Riese, H., Dietrich, A., Ormel, J., Verhulst, F. C., and Oldehinkel, A.
J. (2009). Preadolescents’ somatic and cognitive-aﬀective depressive symptoms
are diﬀerentially related to cardiac autonomic function and cortisol: the TRAILS
study. Psychosom. Med. 71, 944–950. doi: 10.1097/PSY.0b013e3181bc756b
Carney, R. M., Blumenthal, J. A., Stein, P. K., Watkins, L., Catellier, D.,
Berkman, L. F., et al. (2001). Depression, heart rate variability, and acute
myocardial infarction. Circulation 104, 2024–2028. doi: 10.1161/hc4201.
097834
Carney, R. M., and Freedland, K. E. (2012). Are somatic symptoms of depression
better predictors of cardiac events than cognitive symptoms in coronary heart
disease? Psychosom. Med. 74, 33–38. doi: 10.1097/PSY.0b013e3182405ac4
Carney, R. M., Freedland, K. E., Miller, G. E., and Jaﬀe, A. S. (2002). Depression as
a risk factor for cardiac mortality and morbidity: a review of potential mecha-
nisms. J. Psychosom. Res. 53, 897–902. doi: 10.1016/S0022-3999(02)00311-2
Carney, R. M., Freedland, K. E., and Stein, P. K. (2000). Anxiety, depression,
and heart rate variability. Psychosom. Med. 62, 84–86. doi: 10.1097/00006842-
200001000-00013
Carney, R. M., Freedland, K. E., and Veith, R. C. (2005). Depression, the autonomic
nervous system, and coronary heart disease. Psychosom. Med. 67, S29–S33. doi:
10.1097/01.psy.0000162254.61556.d5
Carney, R. M., Rich, M. W., Freedland, K. E., teVelde, A., Saini, J., Simeone, C.,
et al. (1988). Major depressive disorder predicts cardiac events in patients with
coronary artery disease. Psychosom. Med. 50, 627–633. doi: 10.1097/00006842-
198811000-00009
Carney, R. M., Saunders, R. D., Freedland, K. E., Stein, P., Rich, M. W., and
Jaﬀe, A. S. (1995). Association of depression with reduced heart rate variability
in coronary artery disease. Am. J. Cardiol. 76, 562–564. doi: 10.1016/S0002-
9149(99)80155-6
Carvalho Bos, S., Pereira, A. T., Marques, M., Maia, B., Soares, M. J., Valente, J.,
et al. (2009). The BDI-II factor structure in pregnancy and postpartum: two or
three factors? Eur. Psychiatry 24, 334–340. doi: 10.1016/j.eurpsy.2008.10.003
Cohen, H., and Benjamin, J. (2006). Power spectrum analysis and cardio-
vascular morbidity in anxiety disorders. Auton. Neurosci. 128, 1–8. doi:
10.1016/j.autneu.2005.06.007
Dallack, G. W., and Roose, S. P. (1990). Perspectives on the relationship between
cardiovascular disease and aﬀective disorder. J. Clin. Psychiatry 51, 4–9.
de Jonge, P., Mangano, D., and Whooley, M. A. (2007). Diﬀerential associa-
tion of cognitive and somatic depressive symptoms with heart rate variabil-
ity in patients with stable coronary heart disease: ﬁndings from the Heart
and Soul Study. Psychosom. Med. 69, 735–739. doi: 10.1097/PSY.0b013e318
15743ca
de Jonge, P., Ormel, J., van den Brink, R. H., van Melle, J. P., Spijkerman,
T. A., Kuijper, A., et al. (2006). Symptom dimensions of depression following
myocardial infarction and their relationship with somatic health status and car-
diovascular prognosis. Am. J. Psychiatry 163, 138–144. doi: 10.1176/appi.ajp.
163.1.138
Dozois, D. J. A., Dobson, K. S., and Ahnberg, J. L. (1998). A psychometric eval-
uation of the Beck Depression Inventory-II. Psychol. Assess. 10, 83–89. doi:
10.1037/1040-3590.10.2.83
Frontiers in Psychology | www.frontiersin.org 8 May 2015 | Volume 6 | Article 599
Messerotti Benvenuti et al. Depression and heart rate variability
First, M. B., Spitzer, R. L., Gibbon, M., and Williams, J. B. W. (1997). Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID I). Clinical Version.
Washington, DC: American Psychiatric Press, Inc.
Frewen, P. A., and Dozois, D. J. A. (2005). Recognition and interpretation of facial
expressions in dysphoric women. J. Psychopathol. Behav. Assess. 27, 305–315.
doi: 10.1007/s10862-005-2410-z
Friedman, B. H. (2007). An autonomic ﬂexibility-neurovisceral integration
model of anxiety and cardiac vagal tone. Biol. Psychol. 74, 185–199. doi:
10.1016/j.biopsycho.2005.08.009
Gehi, A., Mangano, D., Pipkin, S., Browner, W. S., and Whooley, M. A. (2005).
Depression and heart rate variability in patients with stable coronary heart
disease: ﬁndings from the Heart and Soul Study. Arch. Gen. Psychiatry 62,
661–666. doi: 10.1001/archpsyc.62.6.661
Ghisi, M., Flebus, G. B., Montano, A., Sanavio, E., and Sica, C. (2006).
Beck Depression Inventory-II. BDI-II. Manuale. Florence: O.S. Organizzazioni
Speciali.
Haaga, D. A. F., and Solomon, A. (1993). Impact of Kendall, Hollon, Beck,
Hammen, and Ingram (1987) on treatment of the continuity issue in “depres-
sion” research. Cogn. Ther. Res. 17, 313–324. doi: 10.1007/BF01177657
Imaoka, K., Inoue, H., Inoue, Y., Hazama, H., Tanaka, T., and Yamane, N. (1985).
R-R intervals of ECG in depression. Folia Psychiatr. Neurol. Jpn. 39, 485–488.
doi: 10.1111/j.1440-1819.1985.tb00801.x
Jiang, W., Kuchibhatla, M., Cuﬀe, M. S., Christopher, E. J., Alexander, J. D.,
Clary, G. L., et al. (2004). Prognostic value of anxiety and depression
in patients with chronic heart failure. Circulation 110, 3452–3456. doi:
10.1161/01.CIR.0000148138.25157.F9
Judd, L. L., Rapaport, M. H., Paulus, M. P., and Brown, J. L. (1994). Subsyndromal
symptomatic depression: a new mood disorder? J. Clin. Psychiatry 55, 18–28.
doi: 10.2165/00023210-199401060-00001
Kemp, A. H., Quintana, D. S., Gray, M. A., Felmingham, K. L., Brown, K., and
Gatt, J. M. (2010). Impact of depression and antidepressant treatment on heart
rate variability: a review and meta-analysis. Biol. Psychiatry 67, 1067–1074. doi:
10.1016/j.biopsych.2009.12.012
Kemp, A. H., Quintana, D. S., Quinn, C. R., Hopkinson, P., and Harris, A. W.
(2014). Major depressive disorder with melancholia displays robust alterations
in resting state heart rate and its variability: implications for future morbidity
and mortality. Front. Psychol. 5:1387. doi: 10.3389/fpsyg.2014.01387
Kendall, P. C., Hollon, S. D., Beck, A. T., Hammen, C. L., and Ingrain, R. E. (1987).
Issues and recommendations regarding use of the Beck Depression Inventory.
Cogn. Ther. Res. 11, 289–299. doi: 10.1007/BF01186280
Kessler, R. C., Chiu,W. T., Demler, O., Merikangas, K. R., andWalters, E. E. (2005).
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the
National Comorbidity Survey Replication. Arch. Gen. Psychiatry 62, 617–627.
doi: 10.1001/archpsyc.62.6.617
Kleiger, R. E., Miller, J. P., Bigger, J. T. Jr., and Moss, A. J. (1987). Decreased
heart rate variability and its association with mortality after myocar-
dial infarction. Am. J. Cardiol. 113, 256–262. doi: 10.1016/0002-9149(87)
90795-8
Kop, W. J. (2012). Somatic depressive symptoms, vital exhaustion, and fatigue:
divergent validity of overlapping constructs. Psychosom. Med. 74, 442–445. doi:
10.1097/PSY.0b013e31825f30c7
Korkushko, O. V., Shatilo, V. B., Plachinda, Y., and Shatilo, T. V. (1991).
Autonomic control of cardiac chronotropic function in man as a function of
age: assessment by power spectral analysis of heart rate variability. J. Auton.
Nerv. Syst. 32, 191–198. doi: 10.1016/0165-1838(91)90113-H
Lasa, L., Ayuso-Mateos, J. L., Vázquez-Barquero, J. L., Díez-Manrique, F. J., and
Dowrick, C. F. (2000). The use of the Beck Depression Inventory to screen for
depression in the general population: a preliminary analysis. J. Aﬀect. Disord.
57, 261–265. doi: 10.1016/S0165-0327(99)00088-9
Lespérance, F., Frasure-Smith, N., Juneau, M., and Théroux, P. (2000). Depression
and 1-year prognosis in unstable angina. Arch. Intern. Med. 160, 1354–1360.
doi: 10.1001/archinte.160.9.1354
Linke, S. E., Rutledge, T., Johnson, B. D., Vaccarino, V., Bittner, V., Cornell, C. E.,
et al. (2009). Depressive symptom dimensions and cardiovascular prognosis
among women with suspected myocardial ischemia: a report from the National
Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome
Evaluation. Arch. Gen. Psychiatry 66, 499–507. doi: 10.1001/archgenpsychia-
try.2009.27
Maier, W., Gänsicke, M., and Weiﬀenbach, O. (1997). The relationship between
major and subthreshold variants of unipolar depression. J. Aﬀect. Disord. 45,
41–51. doi: 10.1016/S0165-0327(97)00058-X
Martens, E. J., Hoen, P. W., Mittelhaeuser, M., de Jonge, P., and Denollet, J.
(2010). Symptom dimensions of post-myocardial infarction depression,
disease severity and cardiac prognosis. Psychol. Med. 40, 807–814. doi:
10.1017/S0033291709990997
Martens, E. J., Nyklícek, I., Szabó, B. M., and Kupper, N. (2008). Depression
and anxiety as predictors of heart rate variability after myocardial infarction.
Psychol. Med. 38, 375–383. doi: 10.1017/S0033291707002097
Mazzi, F., Morosini, P., De Girolamo, G., Lussetti, M., and Guaraldi, G. P. (2000).
SCID-I Structured Clinical Interview for DSM-IV Axis I Disorders. Clinical
Version. Firenze: O.S. Organizzazioni Speciali.
McSweeney, J. C., Cody, M., O’Sullivan, P., Elberson, K., Moser, D. K., and Garvin,
B. J. (2003). Women’s early warning symptoms of acute myocardial infarction.
Circulation 108, 2619–2623. doi: 10.1161/01.CIR.0000097116.29625.7C
Miu, A. C., Heilman, R. M., and Miclea, M. (2009). Reduced heart rate variability
and vagal tone in anxiety: trait versus state, and the eﬀects of autogenic training.
Auton. Neurosci. 145, 99–103. doi: 10.1016/j.autneu.2008.11.010
Moser, M., Lehofer, M., Hoehn-Saric, R., McLeod, D. R., Hildebrandt, G.,
Steinbrenner, B., et al. (1998). Increased heart rate in depressed subjects in
spite of unchanged autonomic balance? J. Aﬀect. Disord. 48, 115–124. doi:
10.1016/S0165-0327(97)00164-X
Mozaﬀarian, D., Stein, P. K., Prineas, R. J., and Siscovick, D. S. (2008). Dietary ﬁsh
and omega-3 fatty acid consumption and heart rate variability in US adults.
Circulation 117, 1130–1137. doi: 10.1161/CIRCULATIONAHA.107.732826
Musselman, D. L., Evans, D. L., and Nemeroﬀ, C. B. (1998). The relationship
of depression to cardiovascular disease: epidemiology, biology, and treatment.
Arch. Gen. Psychiatry 55, 580–592. doi: 10.1001/archpsyc.55.7.580
Patron, E., Messerotti Benvenuti, S., Favretto, G., Gasparotto, R., and Palomba, D.
(2014). Depression and reduced heart rate variability after cardiac surgery:
the mediating role of emotion regulation. Auton. Neurosci. 180, 53–58. doi:
10.1016/j.autneu.2013.11.004
Patron, E., Messerotti Benvenuti, S., Favretto, G., Gasparotto, R., and Palomba, D.
(2015). Depression is associated with increased vagal withdrawal during
unpleasant emotional imagery after cardiac surgery. Auton. Neurosci. 189,
75–82. doi: 10.1016/j.autneu.2015.02.002
Patron, E., Messerotti Benvenuti, S., Favretto, G., Valfrè, C., Bonfà, C.,
Gasparotto, R., et al. (2012). Association between depression and heart rate
variability in patients after cardiac surgery: a pilot study. J. Psychosom. Res. 73,
42–46. doi: 10.1016/j.jpsychores.2012.04.013
Pitzalis, M. V., Iacoviello, M., Todarello, O., Fioretti, A., Guida, P., Massari, F.,
et al. (2001). Depression but not anxiety inﬂuences the autonomic control
of heart rate after myocardial infarction. Am. Heart J. 141, 765–771. doi:
10.1067/mhj.2001.114806
Podrid, P. J., Fuchs, T., and Candinas, R. (1990). Role of the sympathetic nervous
system in the genesis of ventricular arrhythmia. Circulation 82, I103–I113.
Puig, J., Freitas, J., Carvalho, M. J., Puga, N., Ramos, J., Fernandes, P., et al. (1993).
Spectral analysis of heart rate variability in athletes. J. Sports Med. Phys. Fitness
33, 44–48.
Rechlin, T., Weis, M., Spitzer, A., and Kaschka, W. F. (1994). Are aﬀective disor-
ders associated with alterations of heart rate variability? J. Aﬀect. Disord. 32,
271–275. doi: 10.1016/0165-0327(94)90091-4
Roest, A. M., Thombs, B. D., Grace, S. L., Stewart, D. E., Abbey, S. E., and
de Jonge, P. (2011). Somatic/aﬀective symptoms, but not cognitive/aﬀective
symptoms, of depression after acute coronary syndrome are associated
with 12-month all-cause mortality. J. Aﬀect. Disord. 131, 158–163. doi:
10.1016/j.jad.2010.11.018
Rottenberg, J. (2007). Cardiac vagal control in depression: a critical analysis. Biol.
Psychol. 74, 200–211. doi: 10.1016/j.biopsycho.2005.08.010
Schiﬀer, A. A., Pelle, A. J., Smith, O. R., Widdershoven, J. W., Hendriks, E. H., and
Pedersen, S. S. (2009). Somatic versus cognitive symptoms of depression as pre-
dictors of all-cause mortality and health status in chronic heart failure. J. Clin.
Psychiatry 70, 1667–1673. doi: 10.4088/JCP.08m04609
Schwartz, P. J., and Vanoli, E. (1981). Cardiac arrhythmias elicited by interaction
between acute myocardial ischemia and sympathetic hyperactivity: a new exper-
imental model for the study of antiarrhythmic drugs. J. Cardiovasc. Pharmacol.
3, 1251–1259. doi: 10.1097/00005344-198111000-00012
Frontiers in Psychology | www.frontiersin.org 9 May 2015 | Volume 6 | Article 599
Messerotti Benvenuti et al. Depression and heart rate variability
Shaﬀer, F., McCraty, R., and Zerr, C. L. (2014). A healthy heart is not a metronome:
an integrative review of the heart’s anatomy and heart rate variability. Front.
Psychol. 5:1040. doi: 10.3389/fpsyg.2014.01040
Silvetti, M. S., Drago, F., and Ragonese, P. (2001). Heart rate variability in healthy
children and adolescents is partially related to age and gender. Int. J. Cardiol.
81, 169–174. doi: 10.1016/S0167-5273(01)00537-X
Smith, O. R., Kupper, N., Schiﬀer, A. A., and Denollet, J. (2012). Somatic
depression predicts mortality in chronic heart failure: can this be explained
by covarying symptoms of fatigue? Psychosom. Med. 74, 459–463. doi:
10.1097/PSY.0b013e31824ef2f4
Smolderen, K. G., Spertus, J. A., Reid, K. J., Buchanan, D. M., Krumholz,
H. M., Denollet, J., et al. (2009). The association of cognitive and
somatic depressive symptoms with depression recognition and outcomes after
myocardial infarction. Circ. Cardiovasc. Qual. Outcomes 2, 328–337. doi:
10.1161/CIRCOUTCOMES.109.868588
Spielberger, C. D., Pedrabissi, L., and Santinello, M. (1996). STAI, State-trait
Anxiety Inventory, Forma Y :Manuale. Florence: O.S. Organizzazioni Speciali.
Sprinkle, S. D., Lurie, D., Insko, S. L., Atkinson, G., Jones, G. L., Logan, A. R.,
et al. (2002). Criterion validity, severity cut scores, and test-retest reliability
of the Beck Depression Inventory-II in a university counseling center sample.
J. Counsel. Psychol. 49, 381–385. doi: 10.1037//0022-0167.49.3.381
Steer, R. A., Ball, R., Ranieri, W. F., and Beck, A. T. (1999). Dimensions of
the Beck Depression Inventory-II in clinically depressed outpatients. J. Clin.
Psychol. 55, 117–128. doi: 10.1002/(SICI)1097-4679(199901)55:1<117::AID-
JCLP12>3.0.CO;2-A
Steer, R. A., Kumar, G., Ranieri, W. F., and Beck, A. T. (1998). Use
of the Beck Depression Inventory-II with adolescent psychiatric outpa-
tients. J. Psychopathol. Behav. Assess. 20, 127–137. doi: 10.1023/A:10230915
29735
Stein, P. E., Carney, R. M., Freedland, K. E., Skala, J. A., Kleiger, R. E., Rottman,
J. N., et al. (2000). Severe depression is associated with markedly reduced heart
rate variability in patients with stable coronary heart disease. J. Psychosom. Res.
48, 493–500. doi: 10.1016/S0022-3999(99)00085-9
Storch, E. A., Roberti, J. W., and Roth, D. A. (2004). Factor structure, concur-
rent validity, and internal consistency of the Beck Depression Inventory-Second
Edition in a sample of college students. Depress. Anxiety 19, 187–189. doi:
10.1002/da.20002
Task Force of the European Society of Cardiology, and the North American
Society for pacing, and electrophysiology. (1996). Heart rate variability: stan-
dards of measurement, physiological interpretation and clinical use.Circulation
93, 1043–1065. doi: 10.1161/01.CIR.93.5.1043
Tennen, H., Hall, J. A., and Aﬄeck, G. (1995). Depression research methodolo-
gies in the Journal of Personality and Social Psychology: a review and critique.
J. Pers. Soc. Psychol. 68, 870–884. doi: 10.1037/0022-3514.68.5.870
Thayer, J. F., and Lane, R. D. (2000). A model of neurovisceral integration in
emotion regulation and dysregulation. J. Aﬀect. Disord. 61, 201–216. doi:
10.1016/S0165-0327(00)00338-4
Van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G., Ormel, J.,
Van Veldhuisen, D. J., et al. (2004). Prognostic association of
depression following myocardial infarction with mortality and car-
diovascular events: a meta-analysis. Psychosom. Med. 66, 814–822. doi:
10.1097/01.psy.0000146294.82810.9c
Vogelzangs, N., Seldenrijk, A., Beekman, A. T., van Hout, H. P., de Jonge, P., and
Penninx, B. W. (2010). Cardiovascular disease in persons with depressive and
anxiety disorders. J. Aﬀect. Disord. 125, 241–248. doi: 10.1016/j.jad.2010.02.112
Ward, L. C. (2006). Comparison of factor structure models for the Beck Depression
Inventory–II. Psychol. Assess. 18, 81–88. doi: 10.1037/1040-3590.18.1.81
Watkins, L. L., Schneiderman, N., Blumenthal, J. A., Sheps, D. S., Catellier, D.,
Taylor, C. B., et al. (2003). Cognitive and somatic symptoms of depression
are associated with medical comorbidity in patients after acute myocardial
infarction. Am. Heart J. 146, 48–54. doi: 10.1016/S0002-8703(03)00083-8
Whisman, M. A., Perez, J. E., and Ramel, W. (2000). Factor structure of the Beck
Depression Inventory-Second Edition (BDI-II) in a student sample. J. Clin.
Psychol. 56, 545–551. doi: 10.1002/(SICI)1097-4679(200004)56:4<545::AID-
JCLP7>3.0.CO;2-U
Wulsin, L. R., and Singal, B. M. (2003). Do depressive symptoms increase the risk
for the onset of coronary disease? A systematic quantitative review. Psychosom.
Med. 65, 201–210. doi: 10.1097/01.PSY.0000058371.50240.E3
Yeragani, V. K., Pohl, R., Balon, R., Ramesh, C., Glitz, D., Jung, I., et al. (1991).
Heart rate variability in patients with major depression. Psychiatry Res. 37,
35–46. doi: 10.1016/0165-1781(91)90104-W
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or ﬁnancial relationships that could be
construed as a potential conﬂict of interest.
Copyright © 2015 Messerotti Benvenuti, Buodo, Mennella and Palomba. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Psychology | www.frontiersin.org 10 May 2015 | Volume 6 | Article 599
